319 results
Page 9 of 16
8-K
EX-99.1
ef4opo1gje0h 449y
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.3
nhh 7ckqgk8
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
4ld9h8rn
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-2.1
jdtb92qgj
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-99.2
4a3r 7koo
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-99.1
drf4o8bg
12 May 22
Yumanity Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Developments
4:52pm
8-K
x1i71k9
8 Apr 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-99.1
z5ka6gtdui0bgud8rv1x
24 Mar 22
Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
10byzanbj64
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K
EX-99.1
edk3lollo6f
17 Feb 22
Yumanity Therapeutics Exploring Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring
8:37am
8-K
EX-99.1
n3h1ou8auik2rdx
19 Jan 22
Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739
7:42am